|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009324,
umls-concept:C0013081,
umls-concept:C0017262,
umls-concept:C0017710,
umls-concept:C0030705,
umls-concept:C0036078,
umls-concept:C0087111,
umls-concept:C0185117,
umls-concept:C0205217,
umls-concept:C1366524,
umls-concept:C2243049,
umls-concept:C2911684
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-11-24
|
|
pubmed:abstractText |
CCL20 expression is known to increase in the mucosal tissues of inflammatory bowel diseases (IBDs). Moreover, the discovery of Nod2 as the IBD1 susceptibility gene has underscored the significance of blood mononuclear cells in IBD pathogenesis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/CCL20 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL20,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Inflammatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Mesalamine,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfasalazine,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0998
|
|
pubmed:author |
pubmed-author:ChoiEun-JuEJ,
pubmed-author:ChoiEun-YoungEY,
pubmed-author:ChoiSuck-CheiSC,
pubmed-author:HanWeon-CheolWC,
pubmed-author:JunChang-DukCD,
pubmed-author:KimSang-WookSW,
pubmed-author:LeeHyun-JuHJ,
pubmed-author:LeeJeong-GeunJG,
pubmed-author:LeeMoo-HyungMH,
pubmed-author:OhHyun-MeeHM,
pubmed-author:ParkKie-InKI,
pubmed-author:SeoGeom-SeogGS,
pubmed-author:YunKi-JungKJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1070-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16306769-Adult,
pubmed-meshheading:16306769-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16306769-Chemokine CCL20,
pubmed-meshheading:16306769-Chemokines, CC,
pubmed-meshheading:16306769-Colitis, Ulcerative,
pubmed-meshheading:16306769-Dexamethasone,
pubmed-meshheading:16306769-Down-Regulation,
pubmed-meshheading:16306769-Female,
pubmed-meshheading:16306769-Glucocorticoids,
pubmed-meshheading:16306769-Humans,
pubmed-meshheading:16306769-Immunohistochemistry,
pubmed-meshheading:16306769-Leukocytes, Mononuclear,
pubmed-meshheading:16306769-Macrophage Inflammatory Proteins,
pubmed-meshheading:16306769-Male,
pubmed-meshheading:16306769-Mesalamine,
pubmed-meshheading:16306769-Sulfasalazine,
pubmed-meshheading:16306769-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment.
|
|
pubmed:affiliation |
Department of Physiology, Kyungpook National University School of Medicine, Taegu, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
